MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 54 filers reported holding MONTE ROSA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $12,831 | +24.8% | 1,820 | 0.0% | 0.00% | – |
| Q4 2023 | $10,283 | +18.0% | 1,820 | 0.0% | 0.00% | – |
| Q3 2023 | $8,718 | -30.1% | 1,820 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $12,467 | -12.1% | 1,820 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $14,178 | -12.4% | 1,820 | -14.4% | 0.00% | 0.0% |
| Q4 2022 | $16,186 | -6.9% | 2,127 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $17,378 | -15.5% | 2,127 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $20,568 | -31.0% | 2,127 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $29,821 | -62.8% | 2,127 | -40.9% | 0.00% | 0.0% |
| Q3 2021 | $80,163 | – | 3,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $32,804,000 | 6.54% |
| Cormorant Asset Management, LP | 3,102,199 | $67,957,000 | 2.76% |
| NEA Management Company, LLC | 7,703,205 | $171,627,000 | 2.04% |
| Avoro Capital Advisors LLC | 3,311,434 | $61,003,000 | 0.96% |
| Octagon Capital Advisors LP | 150,000 | $3,342,000 | 0.82% |
| Alphabet Inc. | 1,464,015 | $32,618,000 | 0.77% |
| Casdin Capital, LLC | 960,883 | $21,408,000 | 0.53% |
| RTW INVESTMENTS, LP | 1,214,572 | $26,005,000 | 0.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 119,647 | $2,666,000 | 0.22% |
| Avidity Partners Management LP | 300,000 | $6,684,000 | 0.15% |